Clever Leaves Partners With SOMAÍ Pharmaceuticals And Sends First Commercial Shipments To Portugal
Portfolio Pulse from Happy Mohamed
Clever Leaves Holdings Inc. (NASDAQ:CLVR) has entered into a five-year agreement with SOMAÍ Pharmaceuticals to supply EU-GMP certified CBD extracts from Colombia to SOMAÍ's operations in Portugal. The first shipments have been completed, and Clever Leaves will continue to supply pharmaceutical-grade APIs and CBD extracts for patients across Europe.
May 25, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clever Leaves' partnership with SOMAÍ Pharmaceuticals and the first commercial shipments to Portugal could boost its position in Europe's medical cannabis market.
The partnership with SOMAÍ Pharmaceuticals and the first commercial shipments to Portugal are significant for Clever Leaves as it expands its presence in the European medical cannabis market. This could lead to increased revenues and growth for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100